238 related articles for article (PubMed ID: 11169203)
1. Role of IgE in primary murine Schistosomiasis mansoni.
El Ridi R; Ragab S; Lewis S; Afifi A
Scand J Immunol; 2001 Jan; 53(1):24-31. PubMed ID: 11169203
[TBL] [Abstract][Full Text] [Related]
2. Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni.
King CL; Xianli J; Malhotra I; Liu S; Mahmoud AA; Oettgen HC
J Immunol; 1997 Jan; 158(1):294-300. PubMed ID: 8977202
[TBL] [Abstract][Full Text] [Related]
3. Human IgE responses to Schistosoma mansoni and resistance to reinfection.
Dunne DW; Butterworth AE; Fulford AJ; Ouma JH; Sturrock RF
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():99-103. PubMed ID: 1343933
[TBL] [Abstract][Full Text] [Related]
4. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
Farah IO; Johansson M; Lövgren-Bengtson K; Hau J
Scand J Immunol; 2000 Mar; 51(3):237-43. PubMed ID: 10736092
[TBL] [Abstract][Full Text] [Related]
5. Human antibody responses to Schistosoma mansoni: the influence of epitopes shared between different life-cycle stages on the response to the schistosomulum.
Dunne DW; Grabowska AM; Fulford AJ; Butterworth AE; Sturrock RF; Koech D; Ouma JH
Eur J Immunol; 1988 Jan; 18(1):123-31. PubMed ID: 2450028
[TBL] [Abstract][Full Text] [Related]
6. Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigens.
Walter K; Fulford AJ; McBeath R; Joseph S; Jones FM; Kariuki HC; Mwatha JK; Kimani G; Kabatereine NB; Vennervald BJ; Ouma JH; Dunne DW
J Immunol; 2006 Oct; 177(8):5490-8. PubMed ID: 17015735
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting high and low human IgE responses to schistosome worm antigens in an area of Brazil endemic for Schistosoma mansoni and hookworm.
Webster M; Correa-Oliveira R; Gazzinelli G; Viana IR; Fraga LA; Silveira AM; Dunne DW
Am J Trop Med Hyg; 1997 Oct; 57(4):487-94. PubMed ID: 9347969
[TBL] [Abstract][Full Text] [Related]
8. Anti-miracidial effect of recombinant glutathione S-transferase 26 and soluble egg antigen on immune responses in murine schistosomiasis mansoni.
Hassanein H; Kamel M; Badawy A; El-Ghorab N; Abdeen H; Zada S; El-Ahwany E; Doughty B
APMIS; 1999 Aug; 107(8):723-36. PubMed ID: 10515123
[TBL] [Abstract][Full Text] [Related]
9. Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons.
Nyindo M; Kariuki TM; Mola PW; Farah IO; Elson L; Blanton RE; King CL
Infect Immun; 1999 Feb; 67(2):636-42. PubMed ID: 9916070
[TBL] [Abstract][Full Text] [Related]
10. Protective monoclonal antibodies from mice vaccinated or chronically infected with Schistosoma mansoni that recognize the same antigens.
Gregoire RJ; Shi MH; Rekosh DM; Loverde PT
J Immunol; 1987 Dec; 139(11):3792-801. PubMed ID: 2445819
[TBL] [Abstract][Full Text] [Related]
11. Neonatal idiotypic exposure alters subsequent cytokine, pathology, and survival patterns in experimental Schistosoma mansoni infections.
Montesano MA; Colley DG; Eloi-Santos S; Freeman GL; Secor WE
J Exp Med; 1999 Feb; 189(4):637-45. PubMed ID: 9989978
[TBL] [Abstract][Full Text] [Related]
12. Impact of interleukin-1 and interleukin-6 in murine primary schistosomiasis.
El Ridi R; Wagih A; Salem R; Mahana N; El Demellawy M; Tallima H
Int Immunopharmacol; 2006 Jul; 6(7):1100-8. PubMed ID: 16714213
[TBL] [Abstract][Full Text] [Related]
13. Systemic delivery of an adenovirus expressing EBV-derived vIL-10 in mice infected with Schistosoma mansoni or Leishmania amazonensis: controversial effects on the development of pathological parameters.
Verwaerde C; Thiam K; Delanoye A; Fernandez-Gomez R; D'Halluin J; Auriault C
Eur Cytokine Netw; 1999 Jun; 10(2):161-70. PubMed ID: 10400822
[TBL] [Abstract][Full Text] [Related]
14.
Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
Front Immunol; 2018; 9():1762. PubMed ID: 30105029
[TBL] [Abstract][Full Text] [Related]
15. Association of Schistosoma mansoni-specific IgG and IgE antibody production and clinical schistosomiasis status in a rural area of Minas Gerais, Brazil.
Negrão-Corrêa D; Fittipaldi JF; Lambertucci JR; Teixeira MM; Antunes CM; Carneiro M
PLoS One; 2014; 9(2):e88042. PubMed ID: 24505371
[TBL] [Abstract][Full Text] [Related]
16. Schistosomal granuloma modulation. III. Schistosma haematobium worms accelerate S. mansoni soluble egg antigen-induced hepatic granuloma formation in vivo.
Jacobs W; Deelder A; Bogers J; Van de Vijver K; Van Marck E
Parasitol Res; 1999 Nov; 85(11):905-9. PubMed ID: 10540951
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni.
Allam G
Immunobiology; 2009; 214(8):712-27. PubMed ID: 19249123
[TBL] [Abstract][Full Text] [Related]
18. Induced tolerance to Schistosoma mansoni antigens modulates periovular granuloma.
Sadigursky M; Falangola MF; Santos Rde O; Cardoso SA; David J
Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():269-71. PubMed ID: 3151102
[TBL] [Abstract][Full Text] [Related]
19. Protective immunization of mice against Schistosoma mansoni with purified adult worm surface membranes.
Smithers SR; Hackett F; Ali PO; Simpson AJ
Parasite Immunol; 1989 Jul; 11(4):301-18. PubMed ID: 2476710
[TBL] [Abstract][Full Text] [Related]
20. Schistosoma mansoni infection in IgE-producing and IgE-deficient mice.
El Ridi R; Ozaki T; Kamiya H
J Parasitol; 1998 Feb; 84(1):171-4. PubMed ID: 9488359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
